EPO and thymoma: It may present as a primary haematological disorder in the absence of any other disease, or secondary to parvovirus infection, collagen vascular disease, leukaemia, lymphoma, thymoma, solid tumors, treatment with recombinant human erythropoietin (EPO) or other drugs, ABO-incompatible haematopoietic stem cell transplantation and pregnancy.